Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice.
[zellweger syndrome]
The
marked
deficiency
of
peroxisomal
organelle
assembly
in
the
PEX
2
(
-
/
-
)
mouse
model
for
Zellweger
syndrome
provides
a
unique
opportunity
to
developmentally
and
biochemically
characterize
hepatic
disease
progression
and
bile
acid
products
.
The
postnatal
survival
of
homozygous
mutants
enabled
us
to
evaluate
the
response
to
bile
acid
replenishment
in
this
disease
state
.
PEX
2
mutant
liver
has
severe
but
transient
intrahepatic
cholestasis
that
abates
in
the
early
postnatal
period
and
progresses
to
steatohepatitis
by
postnatal
day
36
.
We
confirmed
the
expected
reduction
of
mature
C
2
4
bile
acids
,
accumulation
of
C
2
7
-
bile
acid
intermediates
,
and
low
total
bile
acid
level
in
liver
and
bile
from
these
mutant
mice
.
Treating
the
PEX
2
(
-
/
-
)
mice
with
bile
acids
prolonged
postnatal
survival
,
alleviated
intrahepatic
cholestasis
and
intestinal
malabsorption
,
reduced
C
2
7
-
bile
acid
intermediate
production
,
and
prevented
older
mutants
from
developing
severe
steatohepatitis
.
However
,
this
therapy
exacerbated
the
degree
of
hepatic
steatosis
and
worsened
the
already
severe
mitochondrial
and
cellular
damage
in
peroxisome-
deficient
liver
.
Both
untreated
and
bile
acid-fed
PEX
2
(
-
/
-
)
mice
accumulated
high
levels
of
predominantly
unconjugated
bile
acids
in
plasma
because
of
altered
expression
of
hepatocyte
bile
acid
transporters
.
Significant
amounts
of
unconjugated
bile
acids
were
also
found
in
the
liver
and
bile
of
PEX
2
mutants
,
indicating
a
generalized
defect
in
bile
acid
conjugation
.
Peroxisome
deficiency
widely
disturbs
bile
acid
homeostasis
and
hepatic
functioning
in
mice
,
and
the
high
sensitivity
of
the
peroxisome-
deficient
liver
to
bile
acid
toxicity
limits
the
effectiveness
of
bile
acid
therapy
for
preventing
hepatic
disease
.
Diseases
Validation
Diseases presenting
"hepatic steatosis"
symptom
adrenal incidentaloma
aromatase deficiency
cushing syndrome
werner syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
This symptom has already been validated